百花医药
(600721)
| 流通市值：26.24亿 | | | 总市值：26.24亿 |
| 流通股本：3.84亿 | | | 总股本：3.84亿 |
| 报告期 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 272,048,128.25 | 105,220,486.73 | 161,732,145.76 | 80,698,046.32 |
| 应收票据及应收账款 | 84,796,881.78 | 31,763,489.09 | 34,252,337.74 | 26,971,468.13 |
| 其中：应收票据 | 3,832,188.91 | 565,120.44 | 543,710 | 1,004,014.5 |
| 应收账款 | 80,964,692.87 | 31,198,368.65 | 33,708,627.74 | 25,967,453.63 |
| 应收款项融资 | 5,934,432.39 | 6,967,470.03 | 3,106,123.32 | 4,666,925.92 |
| 预付款项 | 3,017,390.57 | 8,656,140.84 | 8,908,166.51 | 9,004,893.96 |
| 其他应收款合计 | 3,700,344.67 | 5,665,810.65 | 4,228,499.94 | 4,171,404.26 |
| 存货 | 99,723,149.71 | 121,358,177.12 | 126,870,992.29 | 132,026,260.69 |
| 合同资产 | 111,303,976.88 | 183,771,871.95 | 176,212,299.09 | 191,460,731.19 |
| 其他流动资产 | 2,747,572.44 | 11,973,956.65 | 11,667,985.56 | 10,535,741.57 |
| 流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 流动资产合计 | 583,271,876.69 | 617,357,403.06 | 602,258,550.21 | 584,415,472.04 |
| 非流动资产: | | | | |
| 长期股权投资 | 59,910,943.3 | 59,931,304.77 | 59,790,754.89 | 59,707,255.46 |
| 其他权益工具投资 | 3,861,309.55 | 3,959,959.1 | 3,959,959.1 | 3,990,651.48 |
| 投资性房地产 | 245,250,300 | 245,375,300 | 245,375,300 | 245,375,300 |
| 固定资产 | 140,026,004.25 | 141,259,184.16 | 145,127,725.8 | 142,516,127.04 |
| 使用权资产 | 79,096.11 | 439,311.8 | 482,965.01 | 1,436,364.07 |
| 无形资产 | 8,413,998.95 | 8,898,610.62 | 9,383,222.31 | 9,597,922.48 |
| 开发支出 | 27,482,385.83 | 21,187,445.72 | 16,958,969.16 | 12,906,785.26 |
| 商誉 | 11,485,077.64 | 11,485,077.64 | 11,485,077.64 | 11,485,077.64 |
| 长期待摊费用 | 2,705,109.19 | 2,718,983.28 | 2,520,648.16 | 2,834,621.94 |
| 递延所得税资产 | 31,776,278.38 | 14,512,040.61 | 14,504,937.08 | 13,823,893.88 |
| 其他非流动资产 | 281,716.26 | 154,592.92 | 524,361.06 | 1,581,114.77 |
| 非流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 非流动资产合计 | 531,272,219.46 | 509,921,810.62 | 510,113,920.21 | 505,255,114.02 |
| 资产平衡项目 | 0 | 0 | 0 | 0 |
| 资产总计 | 1,114,544,096.15 | 1,127,279,213.68 | 1,112,372,470.42 | 1,089,670,586.06 |
| 流动负债: | | | | |
| 应付票据及应付账款 | 86,651,748.4 | 114,618,131.37 | 112,134,876.56 | 101,506,631.38 |
| 应付账款 | 86,651,748.4 | 114,618,131.37 | 112,134,876.56 | 101,506,631.38 |
| 合同负债 | 140,505,029.12 | 137,193,752.77 | 131,584,085.02 | 127,668,087.24 |
| 应付职工薪酬 | 27,347,408.03 | 24,518,354.55 | 21,264,999.7 | 16,510,906.03 |
| 应交税费 | 4,070,131.29 | 3,116,872.25 | 3,180,606.24 | 3,943,101.68 |
| 其他应付款合计 | 40,783,796.36 | 53,514,982.95 | 57,548,213.99 | 57,696,921.47 |
| 应付股利 | 121,146.5 | 121,146.5 | 121,146.5 | 121,146.5 |
| 一年内到期的非流动负债 | 96,927.31 | 176,799.44 | 174,676.99 | 117,824.69 |
| 其他流动负债 | 9,666,042.49 | 7,082,678.29 | 6,766,792.41 | 6,283,548.11 |
| 流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 流动负债合计 | 309,121,083 | 340,221,571.62 | 332,654,250.91 | 313,727,020.6 |
| 非流动负债: | | | | |
| 租赁负债 | - | 236,469.64 | 374,776.43 | 1,398,554.21 |
| 长期应付职工薪酬 | 1,163,724.45 | 726,933.95 | 733,221.68 | 736,470.53 |
| 预计负债 | 1,097,589.71 | 1,097,589.71 | 1,097,589.71 | 1,097,589.71 |
| 递延收益 | 1,059,965.25 | 1,455,558.39 | 1,566,919.12 | 1,764,131.92 |
| 递延所得税负债 | 43,520,015.45 | 43,522,221.58 | 42,995,427.18 | 41,904,599.4 |
| 其他非流动负债 | - | 0 | - | - |
| 非流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 非流动负债合计 | 46,841,294.86 | 47,038,773.27 | 46,767,934.12 | 46,901,345.77 |
| 负债平衡项目 | 0 | 0 | 0 | 0 |
| 负债合计 | 355,962,377.86 | 387,260,344.89 | 379,422,185.03 | 360,628,366.37 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 384,032,635 | 383,123,080 | 381,993,270 | 381,822,020 |
| 资本公积 | 2,265,831,403.37 | 2,265,605,258.16 | 2,260,958,743.34 | 2,259,188,761.74 |
| 其他综合收益 | 7,195,146.14 | 7,293,795.69 | 7,293,795.69 | 7,324,488.07 |
| 盈余公积 | 5,030,274.41 | 5,030,274.41 | 5,030,274.41 | 5,030,274.41 |
| 未分配利润 | -1,903,507,740.63 | -1,921,033,539.47 | -1,922,325,798.05 | -1,924,323,324.53 |
| 归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 归属于母公司股东权益合计 | 758,581,718.29 | 740,018,868.79 | 732,950,285.39 | 729,042,219.69 |
| 股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 股东权益合计 | 758,581,718.29 | 740,018,868.79 | 732,950,285.39 | 729,042,219.69 |
| 负债和股东权益合计 | 1,114,544,096.15 | 1,127,279,213.68 | 1,112,372,470.42 | 1,089,670,586.06 |
| 公告日期 | 2025-03-12 | 2024-10-25 | 2024-08-21 | 2024-04-26 |
| 审计意见(境内) | 标准无保留意见 | | | |